Global Human Herpersvirus 5 (HHV-5) Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Herpersvirus 5 (HHV-5) Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Herpersvirus 5 (HHV-5) Drug by Country/Region, 2017, 2022 & 2028

2.2 Human Herpersvirus 5 (HHV-5) Drug Segment by Type

2.2.1 Ganciclovir

2.2.2 Valerian Gilivir Drugs

2.2.3 Acyclovir Drugs

2.2.4 Valacyclovir Drugs

2.2.5 Foscarnet Sodium Drugs

2.3 Human Herpersvirus 5 (HHV-5) Drug Sales by Type

2.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Herpersvirus 5 (HHV-5) Drug Sale Price by Type (2017-2022)

2.4 Human Herpersvirus 5 (HHV-5) Drug Segment by Application

2.4.1 Immunodeficiency Crowd

2.4.2 Organ Transplant Crowd

2.4.3 CMV Herpes Crowd

2.5 Human Herpersvirus 5 (HHV-5) Drug Sales by Application

2.5.1 Global Human Herpersvirus 5 (HHV-5) Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Herpersvirus 5 (HHV-5) Drug Sale Price by Application (2017-2022)

3 Global Human Herpersvirus 5 (HHV-5) Drug by Company

3.1 Global Human Herpersvirus 5 (HHV-5) Drug Breakdown Data by Company

3.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Annual Sales by Company (2020-2022)

3.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company (2020-2022)

3.2 Global Human Herpersvirus 5 (HHV-5) Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2020-2022)

3.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2020-2022)

3.3 Global Human Herpersvirus 5 (HHV-5) Drug Sale Price by Company

3.4 Key Manufacturers Human Herpersvirus 5 (HHV-5) Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Herpersvirus 5 (HHV-5) Drug Product Location Distribution

3.4.2 Players Human Herpersvirus 5 (HHV-5) Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Herpersvirus 5 (HHV-5) Drug by Geographic Region

4.1 World Historic Human Herpersvirus 5 (HHV-5) Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Annual Revenue by Geographic Region

4.2 World Historic Human Herpersvirus 5 (HHV-5) Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Annual Revenue by Country/Region

4.3 Americas Human Herpersvirus 5 (HHV-5) Drug Sales Growth

4.4 APAC Human Herpersvirus 5 (HHV-5) Drug Sales Growth

4.5 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Growth

4.6 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Growth

5 Americas

5.1 Americas Human Herpersvirus 5 (HHV-5) Drug Sales by Country

5.1.1 Americas Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2017-2022)

5.1.2 Americas Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2022)

5.2 Americas Human Herpersvirus 5 (HHV-5) Drug Sales by Type

5.3 Americas Human Herpersvirus 5 (HHV-5) Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Herpersvirus 5 (HHV-5) Drug Sales by Region

6.1.1 APAC Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2017-2022)

6.1.2 APAC Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2017-2022)

6.2 APAC Human Herpersvirus 5 (HHV-5) Drug Sales by Type

6.3 APAC Human Herpersvirus 5 (HHV-5) Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Herpersvirus 5 (HHV-5) Drug by Country

7.1.1 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2017-2022)

7.1.2 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2022)

7.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type

7.3 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug by Country

8.1.1 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Type

8.3 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Herpersvirus 5 (HHV-5) Drug

10.3 Manufacturing Process Analysis of Human Herpersvirus 5 (HHV-5) Drug

10.4 Industry Chain Structure of Human Herpersvirus 5 (HHV-5) Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Herpersvirus 5 (HHV-5) Drug Distributors

11.3 Human Herpersvirus 5 (HHV-5) Drug Customer

12 World Forecast Review for Human Herpersvirus 5 (HHV-5) Drug by Geographic Region

12.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Region

12.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Forecast by Region (2023-2028)

12.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Herpersvirus 5 (HHV-5) Drug Forecast by Type

12.7 Global Human Herpersvirus 5 (HHV-5) Drug Forecast by Application

13 Key Players Analysis

13.1 Roche

13.1.1 Roche Company Information

13.1.2 Roche Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.1.3 Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Roche Main Business Overview

13.1.5 Roche Latest Developments

13.2 Livzon Pharmaceuticals

13.2.1 Livzon Pharmaceuticals Company Information

13.2.2 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.2.3 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Livzon Pharmaceuticals Main Business Overview

13.2.5 Livzon Pharmaceuticals Latest Developments

13.3 Sichuan Cologne Pharmaceutical

13.3.1 Sichuan Cologne Pharmaceutical Company Information

13.3.2 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.3.3 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sichuan Cologne Pharmaceutical Main Business Overview

13.3.5 Sichuan Cologne Pharmaceutical Latest Developments

13.4 Hubei Branch benefits medicine

13.4.1 Hubei Branch benefits medicine Company Information

13.4.2 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.4.3 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Hubei Branch benefits medicine Main Business Overview

13.4.5 Hubei Branch benefits medicine Latest Developments

13.5 GlaxoSmithKline

13.5.1 GlaxoSmithKline Company Information

13.5.2 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.5.3 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Main Business Overview

13.5.5 GlaxoSmithKline Latest Developments

13.6 Upright and clear

13.6.1 Upright and clear Company Information

13.6.2 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.6.3 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Upright and clear Main Business Overview

13.6.5 Upright and clear Latest Developments

13.7 Chongqing Winbond (acquisition of Sichuan Mingxin)

13.7.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Company Information

13.7.2 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.7.3 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Main Business Overview

13.7.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Latest Developments

13.8 Haikou Kellett

13.8.1 Haikou Kellett Company Information

13.8.2 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.8.3 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Haikou Kellett Main Business Overview

13.8.5 Haikou Kellett Latest Developments

13.9 On the drug new Asia

13.9.1 On the drug new Asia Company Information

13.9.2 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.9.3 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 On the drug new Asia Main Business Overview

13.9.5 On the drug new Asia Latest Developments

13.10 Chongqing Fu'an Pharmaceutical

13.10.1 Chongqing Fu'an Pharmaceutical Company Information

13.10.2 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.10.3 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Chongqing Fu'an Pharmaceutical Main Business Overview

13.10.5 Chongqing Fu'an Pharmaceutical Latest Developments

13.11 Shandong Luo Xin Pharmaceutical

13.11.1 Shandong Luo Xin Pharmaceutical Company Information

13.11.2 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.11.3 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Shandong Luo Xin Pharmaceutical Main Business Overview

13.11.5 Shandong Luo Xin Pharmaceutical Latest Developments

13.12 Yangtze River Pharmaceutical

13.12.1 Yangtze River Pharmaceutical Company Information

13.12.2 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.12.3 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Yangtze River Pharmaceutical Main Business Overview

13.12.5 Yangtze River Pharmaceutical Latest Developments

13.13 Qianjiang Pharmaceuticals

13.13.1 Qianjiang Pharmaceuticals Company Information

13.13.2 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.13.3 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Qianjiang Pharmaceuticals Main Business Overview

13.13.5 Qianjiang Pharmaceuticals Latest Developments

13.14 Wuhan Hualong

13.14.1 Wuhan Hualong Company Information

13.14.2 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product Offered

13.14.3 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Wuhan Hualong Main Business Overview

13.14.5 Wuhan Hualong Latest Developments

14 Research Findings and Conclusion

Table 1. Human Herpersvirus 5 (HHV-5) Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Herpersvirus 5 (HHV-5) Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Ganciclovir

Table 4. Major Players of Valerian Gilivir Drugs

Table 5. Major Players of Acyclovir Drugs

Table 6. Major Players of Valacyclovir Drugs

Table 7. Major Players of Foscarnet Sodium Drugs

Table 8. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)

Table 9. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2022)

Table 10. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Human Herpersvirus 5 (HHV-5) Drug Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)

Table 14. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2022)

Table 15. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2017-2022)

Table 16. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Human Herpersvirus 5 (HHV-5) Drug Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Company (2020-2022) & (K Units)

Table 19. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company (2020-2022)

Table 20. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Human Herpersvirus 5 (HHV-5) Drug Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Human Herpersvirus 5 (HHV-5) Drug Producing Area Distribution and Sales Area

Table 24. Players Human Herpersvirus 5 (HHV-5) Drug Products Offered

Table 25. Human Herpersvirus 5 (HHV-5) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2017-2022) & (K Units)

Table 37. Americas Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)

Table 41. Americas Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)

Table 43. Americas Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2017-2022) & (K Units)

Table 45. APAC Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)

Table 49. APAC Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)

Table 51. APAC Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2017-2022) & (K Units)

Table 53. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)

Table 57. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)

Table 59. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Human Herpersvirus 5 (HHV-5) Drug

Table 69. Key Market Challenges & Risks of Human Herpersvirus 5 (HHV-5) Drug

Table 70. Key Industry Trends of Human Herpersvirus 5 (HHV-5) Drug

Table 71. Human Herpersvirus 5 (HHV-5) Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Human Herpersvirus 5 (HHV-5) Drug Distributors List

Table 74. Human Herpersvirus 5 (HHV-5) Drug Customer List

Table 75. Global Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Forecast by Region

Table 77. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. Roche Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. Roche Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 97. Roche Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Roche Main Business

Table 99. Roche Latest Developments

Table 100. Livzon Pharmaceuticals Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 102. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Livzon Pharmaceuticals Main Business

Table 104. Livzon Pharmaceuticals Latest Developments

Table 105. Sichuan Cologne Pharmaceutical Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 107. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Sichuan Cologne Pharmaceutical Main Business

Table 109. Sichuan Cologne Pharmaceutical Latest Developments

Table 110. Hubei Branch benefits medicine Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 112. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Hubei Branch benefits medicine Main Business

Table 114. Hubei Branch benefits medicine Latest Developments

Table 115. GlaxoSmithKline Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 117. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. GlaxoSmithKline Main Business

Table 119. GlaxoSmithKline Latest Developments

Table 120. Upright and clear Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 122. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Upright and clear Main Business

Table 124. Upright and clear Latest Developments

Table 125. Chongqing Winbond (acquisition of Sichuan Mingxin) Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 127. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. Chongqing Winbond (acquisition of Sichuan Mingxin) Main Business

Table 129. Chongqing Winbond (acquisition of Sichuan Mingxin) Latest Developments

Table 130. Haikou Kellett Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 132. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Haikou Kellett Main Business

Table 134. Haikou Kellett Latest Developments

Table 135. On the drug new Asia Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 137. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. On the drug new Asia Main Business

Table 139. On the drug new Asia Latest Developments

Table 140. Chongqing Fu'an Pharmaceutical Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 141. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 142. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Chongqing Fu'an Pharmaceutical Main Business

Table 144. Chongqing Fu'an Pharmaceutical Latest Developments

Table 145. Shandong Luo Xin Pharmaceutical Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 146. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 147. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. Shandong Luo Xin Pharmaceutical Main Business

Table 149. Shandong Luo Xin Pharmaceutical Latest Developments

Table 150. Yangtze River Pharmaceutical Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 151. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 152. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. Yangtze River Pharmaceutical Main Business

Table 154. Yangtze River Pharmaceutical Latest Developments

Table 155. Qianjiang Pharmaceuticals Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 156. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 157. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. Qianjiang Pharmaceuticals Main Business

Table 159. Qianjiang Pharmaceuticals Latest Developments

Table 160. Wuhan Hualong Basic Information, Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base, Sales Area and Its Competitors

Table 161. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product Offered

Table 162. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 163. Wuhan Hualong Main Business

Table 164. Wuhan Hualong Latest Developments

List of Figures

Figure 1. Picture of Human Herpersvirus 5 (HHV-5) Drug

Figure 2. Human Herpersvirus 5 (HHV-5) Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Herpersvirus 5 (HHV-5) Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Ganciclovir

Figure 10. Product Picture of Valerian Gilivir Drugs

Figure 11. Product Picture of Acyclovir Drugs

Figure 12. Product Picture of Valacyclovir Drugs

Figure 13. Product Picture of Foscarnet Sodium Drugs

Figure 14. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type in 2021

Figure 15. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type (2017-2022)

Figure 16. Human Herpersvirus 5 (HHV-5) Drug Consumed in Immunodeficiency Crowd

Figure 17. Global Human Herpersvirus 5 (HHV-5) Drug Market: Immunodeficiency Crowd (2017-2022) & (K Units)

Figure 18. Human Herpersvirus 5 (HHV-5) Drug Consumed in Organ Transplant Crowd

Figure 19. Global Human Herpersvirus 5 (HHV-5) Drug Market: Organ Transplant Crowd (2017-2022) & (K Units)

Figure 20. Human Herpersvirus 5 (HHV-5) Drug Consumed in CMV Herpes Crowd

Figure 21. Global Human Herpersvirus 5 (HHV-5) Drug Market: CMV Herpes Crowd (2017-2022) & (K Units)

Figure 22. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2022)

Figure 23. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application in 2021

Figure 24. Human Herpersvirus 5 (HHV-5) Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company in 2021

Figure 26. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Human Herpersvirus 5 (HHV-5) Drug Sales 2017-2022 (K Units)

Figure 31. Americas Human Herpersvirus 5 (HHV-5) Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Human Herpersvirus 5 (HHV-5) Drug Sales 2017-2022 (K Units)

Figure 33. APAC Human Herpersvirus 5 (HHV-5) Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Human Herpersvirus 5 (HHV-5) Drug Sales 2017-2022 (K Units)

Figure 35. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country in 2021

Figure 39. Americas Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country in 2021

Figure 40. United States Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region in 2021

Figure 45. APAC Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Regions in 2021

Figure 46. China Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country in 2021

Figure 53. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country in 2021

Figure 54. Germany Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Human Herpersvirus 5 (HHV-5) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Human Herpersvirus 5 (HHV-5) Drug in 2021

Figure 67. Manufacturing Process Analysis of Human Herpersvirus 5 (HHV-5) Drug

Figure 68. Industry Chain Structure of Human Herpersvirus 5 (HHV-5) Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles